- ISIN DE000A289VV1
- Country Deutschland
Upcoming Webcasts
Past Webcasts
Latest News
News Functions
Additional Functions
30 November 2023
HAEMATO AG
HAEMATO AG: Termination of listing in the Open Market
16 November 2023
HAEMATO AG
HAEMATO AG publishes figures for the third quarter of 2023: Sales increase of around 13% compared to the same period of the previous year, strong increase in EBIT margin and significant increase in
15 November 2023
HAEMATO AG
Termination of the botulinum toxin project
31 August 2023
HAEMATO AG
HAEMATO AG publishes figures for the first half of 2023
31 May 2023
HAEMATO AG
HAEMATO AG with a strong start into the year 2023: Revenue increase of over 25% compared to the same quarter of the previous year and disproportionate increase in the operating result
16 May 2023
HAEMATO AG
HAEMATO AG: Dividend of EUR 1.20
Upcoming Events
Latest Reports
News Functions
Additional Functions
30 October 2023
HAEMATO AG
Half-yearly financial statements 2023
9 June 2023
HAEMATO AG
Annual financial statements 2022
7 October 2022
HAEMATO AG
Half-yearly financial statements 2022
Latest Research
News Functions
Additional Functions
15 December 2023
HAEMATO AG
Original-Research: HAEMATO AG (von GBC AG): ausgesetzt
HAEMATO AG
Original-Research: HAEMATO AG (von GBC AG): suspended
13 December 2023
HAEMATO AG
Original-Research: Haemato AG (von First Berlin Equity Research GmbH): Not Rated
18 September 2023
HAEMATO AG
Original-Research: Haemato AG (von First Berlin Equity Research GmbH): Kaufen
14 September 2023
HAEMATO AG
Original-Research: HAEMATO AG (von GBC AG): BUY
HAEMATO AG
Original-Research: HAEMATO AG (von GBC AG): Kaufen